Jiang Zhong Pharmaceutical Co.,Ltd

Shanghai Stock Exchange 600750.SS

Jiang Zhong Pharmaceutical Co.,Ltd EPS (Diluted) for the year ending December 31, 2023: USD 0.16

Jiang Zhong Pharmaceutical Co.,Ltd EPS (Diluted) is USD 0.16 for the year ending December 31, 2023, a 13.40% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.

Jiang Zhong Pharmaceutical Co.,Ltd EPS (Diluted) for the year ending December 31, 2022 was USD 0.14, a 10.49% change year over year.
Jiang Zhong Pharmaceutical Co.,Ltd EPS (Diluted) for the year ending December 31, 2021 was USD 0.13, a 9.58% change year over year.
Jiang Zhong Pharmaceutical Co.,Ltd EPS (Diluted) for the year ending December 31, 2020 was USD 0.11, a 8.13% change year over year.
Jiang Zhong Pharmaceutical Co.,Ltd EPS (Diluted) for the year ending December 31, 2019 was USD 0.11, a -2.55% change year over year.

Key data

Date	EPS (Diluted)	Shares (Diluted, Weighted)	Shares (Basic, Weighted)	Revenue

Shanghai Stock Exchange: 600750.SS

Jiang Zhong Pharmaceutical Co.,Ltd

CEO	Mr. Wenbin Xiao
IPO Date	Sept. 23, 1996
Location	China
Headquarters	No. 788 Torch Street
Employees	4,013
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

Jiang Zhong Pharmaceutical Co.,Ltd engages in the research and development, production, and sale of traditional Chinese medicine and health foods. The company offers OTC class products for gastrointestinal digestion, upper respiratory tract, and tonics; protein nutrition, tonics, health regimen, probiotics, daily protection, beauty, bone health, and plant liver protection health products; and prescription products. It sells its products under the Jiangzhong and Jianweixiaoshi brands. Jiang Zhong Pharmaceutical Co.,Ltd is based in Nanchang, China.

Key trends

Past 5 years